Unlike TfR, HER2 is not ubiquitously expressed in all tissues, so the fluorescence signal is restricted to the tumor composed of HER2 overexpressing human breast cancer cells, and occasionally, to some extent, to livers and bladders due to degradation and excretion. The gene discussed is ERBB2; the disease is breast cancer.